+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Oncogene"

From
Myc Proto Oncogene Protein - Pipeline Insight, 2024 - Product Thumbnail Image

Myc Proto Oncogene Protein - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
From
From
NGS-Based RNA-Sequencing - Global Strategic Business Report - Product Thumbnail Image

NGS-Based RNA-Sequencing - Global Strategic Business Report

  • Report
  • March 2025
  • 196 Pages
  • Global
From
From
From
Relapsed or Refractory Myelodysplastic Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Relapsed or Refractory Myelodysplastic Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Clear Cell Sarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Clear Cell Sarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
From
Loading Indicator

The Oncogene market is a subset of the Genomics market that focuses on the study of cancer-causing genes. Oncogenes are genes that have the potential to cause cancer when they are mutated or expressed at high levels. Oncogenes are studied to understand the molecular basis of cancer and to develop new treatments. Research in this field has led to the development of targeted therapies, such as monoclonal antibodies, small molecule inhibitors, and gene therapies. The Oncogene market is highly competitive, with many companies developing new technologies and treatments. Companies in the market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, and Bio-Rad Laboratories. Show Less Read more